postoperative adjuvant chemotherapy
k18-065
Unknown small_molecule active
Quick answer
postoperative adjuvant chemotherapy for Small-cell Lung Cancer is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Small-cell Lung Cancer
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active